AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...
AstraZeneca said on Thursday it has received a notice in China over unpaid taxes related to the import of two cancer therapies, as the drugmaker continues to gauge the impact of probes into certain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results